Share Article

Urenco Chairman Knighted in 2014 Queen’s Birthday Honours

16 June 2014 Global News

The Urenco Board is delighted to announce that Chairman, Dr John Hood, has received a Knighthood in the 2014 Queen's Birthday Honours list. 

Dr Hood has been made a Knights Companion with the title Sir John Hood KNZM for his services to tertiary education. 

Helmut Engelbrecht, CEO, Urenco, comments:

“John has made an outstanding contribution to education both in New Zealand and in the UK. On behalf of the Urenco Group, I congratulate him on the honour bestowed.”

Share Article

Line

More global stories

Urenco takes on first interns from IAEA Marie Sklodowska-Curie programme

Global 11 August 2025

Urenco has welcomed its first interns from an industry-leading women-in-nuclear programme that it has supported for more than five years.

Read more

Urenco has welcomed its first interns from an industry-leading women-in-nuclear programme that it has supported for more than five years.

Read more

Half Year 2025 unaudited financial results

Global 06 August 2025

Urenco today announces its results for the half-year ended 30 June 2025.

Read more

Urenco today announces its results for the half-year ended 30 June 2025.

Read more

About Urenco

Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.

With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.

Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.